Related Experiment Video
Updated: Feb 22, 2026

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Synergistic interaction of the cannabinoid and death receptor systems - a potential target for future cancer
Attila Keresztes1, John M Streicher1
1Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA.
Abstract:
Cannabinoid receptors have been shown to interact with other receptors, including tumor necrosis factor receptor superfamily (TNFRS) members, to induce cancer cell death. When cannabinoids and death-inducing ligands (including TNF-related apoptosis-inducing ligand) are administered together, they have been shown to synergize and demonstrate enhanced antitumor activity in vitro. Certain cannabinoid ligands have been shown to sensitize cancer cells and synergistically interact with members of the TNFRS, thus suggesting that the combination of cannabinoids with death receptor (DR) ligands induces additive or synergistic tumor cell death. This review summarizes recent findings on the interaction of the cannabinoid and DR systems and suggests possible clinical co-application of cannabinoids and DR ligands in the treatment of various malignancies.
Insights
Cannabinoids and death receptor ligands synergize to enhance cancer cell death. This review explores their combined potential for treating malignancies.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- Cannabinoid receptors interact with tumor necrosis factor receptor superfamily (TNFRS) members.
- This interaction can induce cancer cell death.
- Cannabinoids and death receptor ligands show synergistic antitumor effects in vitro.
Purpose of the Study:
- To review the interaction between cannabinoid and death receptor (DR) systems.
- To explore the potential of combining cannabinoids with DR ligands for cancer therapy.
Main Methods:
- Literature review of studies on cannabinoid-TNFRS interactions.
- Analysis of in vitro data on combined cannabinoid and DR ligand administration.
- Synthesis of findings on synergistic effects in cancer cell death.
Main Results:
- Cannabinoids sensitize cancer cells to DR ligands.
- Combined administration of cannabinoids and DR ligands enhances antitumor activity.
- Evidence suggests additive or synergistic tumor cell death.
Conclusions:
- The cannabinoid and DR systems interact to induce cancer cell death.
- Co-application of cannabinoids and DR ligands is a promising strategy for treating various malignancies.
- Further clinical research is warranted to validate this therapeutic approach.
More Related Videos
07:40A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Combined Effects of Drugs: Synergism
Such synergistic combinations...
The Extrinsic Apoptotic Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Opioid Receptors: Overview
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...